-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
NRX Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q1 2024.
- NRX Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 8.85M shares, a 33.2% increase year-over-year.
- NRX Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 65.8M shares, a 40.2% increase from 2021.
- NRX Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 46.9M shares, a 36.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)